TRANSGENE (EPA:TNG) | WebDisclosure

BRIEF

published on 11/06/2025 at 08:35, 2 months 25 days ago

Transgene to Present VacDesignR® Tool at ESMO AI 2025

Transgene VacDesignR® INTV ESMO AI 2025 HPV-negative Cancer
PRESS RELEASE

published on 11/06/2025 at 08:30, 2 months 25 days ago

Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines
Transgene to present VacDesignR® tool at ESMO-AI 2025 for optimized cancer vaccine design. Tool enhances virus efficiency and yield for individualized therapies

Cancer Vaccines Computational Tool Transgene VacDesignR ESMO-AI 2025
BRIEF

published on 11/04/2025 at 17:55, 2 months 27 days ago

Transgene présente ses avancées et sa situation financière au T3 2025

Financement Immunothérapie Transgene TG4050 SITC 2025
BRIEF

published on 11/04/2025 at 17:55, 2 months 27 days ago

Transgene presents its progress and financial situation as of Q3 2025

Funding Immunotherapy Transgene TG4050 SITC 2025
PRESS RELEASE

published on 11/04/2025 at 17:50, 2 months 27 days ago

Transgene Provides Business and Financial Update for Q3 2025
Transgene provides business and financial update for Q3 2025, including immunogenicity data of INTV TG4050 in Phase I study on HNSCC. Company focuses on cancer immunotherapies

Financial Update Transgene INTV TG4050 Cancer Immunotherapies HNSCC
PRESS RELEASE

published on 11/04/2025 at 17:50, 2 months 27 days ago

Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025
Transgene fait le point sur ses activités et sa situation financière au troisième trimestre 2025, notamment sur les avancées de son vaccin thérapeutique TG4050 contre le cancer de la tête et du cou

Cancer Situation Financière Transgene TG4050 Vaccin Thérapeutique
BRIEF

published on 10/20/2025 at 08:35, 3 months 12 days ago

Transgene and BioInvent's BT-001 Shows Promising Antitumor Activity

Cancer Immunotherapy Transgene Oncolytic Virus BT-001 Antitumoral Activity
BRIEF

published on 10/20/2025 at 08:35, 3 months 12 days ago

Le BT-001 de Transgene et BioInvent présente une activité antitumorale prometteuse

Immunothérapie Contre Le Cancer Transgene Virus Oncolytique BT-001 Activité Antitumorale
PRESS RELEASE

published on 10/20/2025 at 08:30, 3 months 12 days ago

Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
Transgene and BioInvent's BT-001 oncolytic virus in combination with pembrolizumab shows positive antitumoral activity in refractory tumors. Exciting clinical data presented at ESMO 2025

Transgene Oncolytic Virus BioInvent BT-001 Pembrolizumab
BRIEF

published on 06/13/2025 at 08:35, 7 months 18 days ago

Transgene s'engage auprès des principales plateformes de l'industrie biotechnologique

Immunothérapie Traitement Du Cancer Transgene Données Cliniques Réunions Biotech

Published on 01/31/2026 at 03:15, 1 day 19 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 20 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 20 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 22 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 23 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 02/01/2026 at 20:25, 1 hour 55 minutes ago

WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 6 hours ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 9 hours ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 19 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call

View all EQS

Published on 01/30/2026 at 18:40, 2 days 3 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 2 days 4 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 2 days 4 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 4 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 13 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News